*****MannKind: EpiPen Breathes New Life Into The Stock Until Sales Pick Up Sep. 1, 2016 9:19 AM ET Trent Welsh Summary •Mylan's EpiPen price hikes get blasted in the latest pharmaceutical scandal. •MannKind has an inhalable formulation of epinephrine in its pipeline. •A couple of reasons this is positive for MannKind going forward. http://seekingalpha.com/article/4003555-mannkind-epipen-rescue?auth_param=1vat:1bsg8vj:3778a77cc43af31019e12ffa637f321d&uprof=51#alt2